BOK Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
15,525
+571
+4% +$38.9K 0.02% 407
2026
Q1
$966K Sell
14,954
-1,096
-7% -$77.3K 0.01% 431
2025
Q4
$1.08M Buy
+16,050
New +$1.08M 0.02% 412
2025
Q3
Sell
-15
Closed -$780 1128
2025
Q2
$780 Sell
15
-7,739
-100% -$440K ﹤0.01% 1097
2025
Q1
$495K Buy
7,754
+7,654
+7,654% +$445K 0.01% 563
2024
Q4
$5.28K Buy
100
+8
+9% +$410 ﹤0.01% 1032
2024
Q3
$5.56K Hold
92
﹤0.01% 1049
2024
Q2
$4.82K Buy
+92
New +$4.04K ﹤0.01% 1000
2023
Q1
Sell
-3,532
Closed -$201K 1200
2022
Q4
$201K Buy
+3,532
New +$181K ﹤0.01% 855

Other funds holding HALO

BOK Financial's HALO Position: Q2 2026 in Review

BOK Financial increased its Halozyme (HALO) stake by 3.8% in Q2 2026, buying an estimated $38.9K and bringing the position to 15,525 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #407.

BOK Financial first reported a position in HALO in Q4 2022 and has held it in 9 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • BOK Financial held 15,525 shares of Halozyme worth $1.22M as of Q2 2026.
  • BOK Financial bought 571 Halozyme shares in Q2 2026, an estimated $38.9K.
  • Halozyme made up 0.02% of BOK Financial's portfolio in Q2 2026, its #407 holding.
  • BOK Financial first reported a position in Halozyme in Q4 2022 and has held it in 9 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.